Peter Bergman

ORCID: 0000-0003-3306-3713
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vitamin D Research Studies
  • Antimicrobial Peptides and Activities
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Immunodeficiency and Autoimmune Disorders
  • Immune Response and Inflammation
  • Pediatric health and respiratory diseases
  • Immune Cell Function and Interaction
  • Vitamin C and Antioxidants Research
  • Gut microbiota and health
  • Diet and metabolism studies
  • Plant and animal studies
  • Cystic Fibrosis Research Advances
  • Pharmacological Effects and Toxicity Studies
  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Streptococcal Infections and Treatments
  • Microbial infections and disease research
  • Insect and Arachnid Ecology and Behavior
  • Respiratory viral infections research
  • Lipoproteins and Cardiovascular Health
  • Workplace Health and Well-being
  • Neuropeptides and Animal Physiology
  • Immunotherapy and Immune Responses
  • Chronic Lymphocytic Leukemia Research

Karolinska University Hospital
2016-2025

Karolinska Institutet
2016-2025

Svenska Örtmedicinska Institute
2023

Stockholm University
2022

Rockefeller University
2022

National Bureau of Economic Research
2021

The University of Texas at Austin
2021

Columbia University
2018

National Center for Infectious Diseases
2015

Czech Academy of Sciences, Institute of Microbiology
2015

Abstract The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant concern (VOC) has destabilized global efforts to control impact disease 2019 (COVID-19). Recent data have suggested that B.1.1.529 can readily infect people with naturally acquired or vaccine-induced immunity, facilitated in some cases by viral escape from antibodies neutralize ancestral SARS-CoV-2. However, appears be relatively uncommon such individuals, highlighting a...

10.1038/s41591-022-01700-x article EN cc-by Nature Medicine 2022-01-14
Takaki Asano Bertrand Boisson Fanny Onodi Daniela Matuozzo Marcela Moncada‐Vélez and 95 more Majistor Raj Luxman Maglorius Renkilaraj Peng Zhang Laurent Meertens Alexandre Bolze Marie Materna Sarantis Korniotis Adrian Gervais Estelle Talouarn Benedetta Bigio Yoann Seeleuthner Kaya Bilgüvar Yu Zhang Anna‐Lena Neehus Masato Ogishi Simon J. Pelham Tom Le Voyer Jérémie Rosain Quentin Philippot Pere Soler‐Palacín Roger Colobrán Andrea Martín-Nalda Jacques G. Rivière Yacine Tandjaoui-Lambiotte Khalil Chaïbi Mohammad Shahrooei Ilad Alavi Darazam Nasrin Alipour Olyaei Davood Mansouri Nevin Hatipoğlu Figen Palabıyık Tayfun Özçelık Giuseppe Novelli Antonio Novelli Giorgio Casari Alessandro Aiuti Paola Carrera Simone Bondesan Federica Barzaghi Patrizia Rovere-Querini Cristina Tresoldi José Luis Franco Julian Rojas Luis Felipe Reyes Ingrid G. Bustos Andrés A. Arias Guillaume Morelle Christèle Kyheng Jesús Troya Laura Planas‐Serra Agatha Schlüter Marta Gut Aurora Pujol Luís M. Allende Carlos Rodríguez‐Gallego Carlos Flores Óscar Cabrera-Marante Daniel E. Pleguezuelo Rebeca Pérez de Diego Sevgi Keleş Gökhan Aytekіn Özge Metin Akcan Yenan T. Bryceson Peter Bergman Petter Brodin Daniel Smole Smith Rjh Anna-Carin Norlin Tessa M. Campbell Laura Covill Lennart Hammarström Qiang Pan‐Hammarström Hassan Abolhassani Shrikant Mane Nico Marr Manar Ata Fatima Al Ali Taushif Khan András N. Spaan Clifton L. Dalgard Paolo Bonfanti Andrea Biondi Sarah Tubiana Charles Burdet Robert L. Nussbaum Amanda Kahn-Kirby Andrew L. Snow Jacinta Bustamante Anne Puel Stéphanie Boisson‐Dupuis Shen‐Ying Zhang Vivien Béziat Richard P. Lifton Paul Bastard Luigi D. Notarangelo Laurent Abel

Autosomal inborn errors of type I IFN immunity and autoantibodies against these cytokines underlie at least 10% critical COVID-19 pneumonia cases. We report very rare, biochemically deleterious X-linked TLR7 variants in 16 unrelated male individuals aged 7 to 71 years (mean: 36.7 years) from a cohort 1,202 patients 0.5 99 52.9 with unexplained pneumonia. None the 331 asymptomatically or mildly infected 1.3 102 38.7 tested carry such (p = 3.5 × 10-5). The phenotypes five hemizygous relatives...

10.1126/sciimmunol.abl4348 article EN cc-by Science Immunology 2021-08-10

The microbial metabolite Trimethylamine-N-oxide (TMAO) has been linked to adverse cardiovascular outcome and mortality in the general population.To assess contribution of TMAO inflammation chronic kidney disease (CKD) patients ranging from mild-moderate end-stage 1) associations with glomerular filtration rate (GFR) 2) effect dialysis renal transplantation (Rtx) 3) association inflammatory biomarkers 4) its predictive value for all-cause mortality.Levels metabolites were quantified by a...

10.1371/journal.pone.0141738 article EN cc-by PLoS ONE 2016-01-11
Daniela Matuozzo Estelle Talouarn Astrid Marchal Peng Zhang Jérémy Manry and 95 more Yoann Seeleuthner Yu Zhang Alexandre Bolze Matthieu Chaldebas Baptiste Milisavljevic Adrian Gervais Paul Bastard Takaki Asano Lucy Bizien Federica Barzaghi Hassan Abolhassani Ahmad Abou Tayoun Alessandro Aiuti Ilad Alavi Darazam Luis M. Allende Rebeca Alonso‐Arias Andrés A. Arias Gökhan Aytekіn Peter Bergman Simone Bondesan Yenan T. Bryceson Ingrid G. Bustos Óscar Cabrera-Marante Sheila Cárcel Paola Carrera Giorgio Casari Khalil Chaïbi Roger Colobrán Antônio Condino‐Neto Laura Covill Ottavia M. Delmonte Loubna El Zein Carlos Flores Peter K. Gregersen Marta Gut Filomeen Haerynck Rabih Halwani Selda Hançerli Lennart Hammarström Nevin Hatipoğlu Adem Karbuz Sevgi Keleş Christèle Kyheng Rafael León‐López José Luis Franco Davood Mansouri Javier Martínez‐Picado Özge Metin Akcan Isabelle Migeotte Pierre‐Emmanuel Morange Guillaume Morelle Andrea Martín-Nalda Giuseppe Novelli Antonio Novelli Tayfun Özçelık Figen Palabıyık Qiang Pan‐Hammarström Rebeca Pérez de Diego Laura Planas‐Serra Daniel E. Pleguezuelo Carolina Prando Aurora Pujol Luis Felipe Reyes Jacques G. Rivière Carlos Rodríguez‐Gallego Julián Rojas Patrizia Rovere‐Querini Agatha Schlüter Mohammad Shahrooei Ali Sobh Pere Soler‐Palacín Yacine Tandjaoui-Lambiotte Imran Tipu Cristina Tresoldi Jesús Troya Diederik van de Beek Mayana Zatz Paweł Zawadzki Saleh Zaid Al-Muhsen Mohammed F. Alosaimi Fahad Alsohime Hagit Baris Feldman Manish J. Butte Stefan N. Constantinescu Megan A. Cooper Clifton L. Dalgard Jacques Fellay James R. Heath YL Lau Richard P. Lifton Tom Maniatis Trine H. Mogensen Horst von Bernuth Alban Lermine Michel Vidaud

Abstract Background We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent interferon (IFN) immunity or autoantibodies against IFN, account for 15–20% cases life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants remain be identified ~ 80% cases. Methods report here a genome-wide rare variant burden association analysis 3269 patients with COVID-19, 1373 SARS-CoV-2-infected individuals without pneumonia. Among 928...

10.1186/s13073-023-01173-8 article EN cc-by Genome Medicine 2023-04-05

T cells are critical in mediating the early control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection. However, it remains unknown whether memory can effectively cross-recognize new SARS-CoV-2 variants with a broad array mutations, such as emergent hypermutated BA.2.86 variant. Here, we report two separate cohorts, including healthy controls and individuals chronic lymphocytic leukemia, that spike-specific CD4

10.1016/j.chom.2023.12.010 article EN cc-by Cell Host & Microbe 2024-01-10

Shigella is a major cause of morbidity, mortality, and growth retardation for children in developing countries. Emergence antibiotic resistance among Shigellae demands the development effective medicines. Previous studies found that endogenous antimicrobial peptide LL-37 down-regulated rectal epithelium patients during shigellosis butyrate up-regulates expression colonic epithelial cells vitro decreases severity inflammation experimental shigellosis. In this study, Shigella-infected...

10.1073/pnas.0602888103 article EN Proceedings of the National Academy of Sciences 2006-06-02

The antimicrobial peptide LL-37 is the only cathelicidin that has been described in humans. exerts chemotactic, immunomodulatory and angiogenic effects; activities are mediated through binding to formyl receptor like (FPRL)-1 receptor. Agonistic ligation of FPRL-1 can also induce down-regulation HIV-1 chemokine receptors reduce susceptibility infection vitro. Therefore, we have evaluated capacity inhibit Here demonstrate inhibits replication PBMC, including primary CD4+ T cells. This...

10.2174/157016207781023947 article EN Current HIV Research 2007-06-26

Low serum levels of 25-hydroxyvitamin D(3) are associated with an increased risk respiratory tract infections (RTIs). Clinical trials vitamin against various have been carried out but data so far not conclusive. Thus, there is a need for additional randomised controlled effects on infections.To investigate if supplementation could reduce infectious symptoms and antibiotic consumption among patients antibody deficiency or frequent RTIs.A double-blind trial.Karolinska University Hospital,...

10.1136/bmjopen-2012-001663 article EN cc-by-nc BMJ Open 2012-01-01

LL-37 is a human antimicrobial peptide (AMP) of the cathelicidin family with multiple activities including mediator vitamin D-induced autophagy in macrophages, resulting intracellular killing Mycobacterium tuberculosis (Mtb). In previous trial healthy volunteers, we have shown that expression and subsequent Mtb-killing can be further enhanced by 4-phenylbutyrate (PBA), also an inducer expression. Here, explore potential mechanism(s) behind PBA LL-37-induced Mtb. Mtb infection macrophages...

10.1080/15548627.2015.1075110 article EN Autophagy 2015-07-28

Background Development of new tuberculosis (TB) drugs and alternative treatment strategies are urgently required to control the global spread TB. Previous results have shown that vitamin D3 (vitD3) 4-phenyl butyrate (PBA) potent inducers host defense peptide LL-37 possess anti-mycobacterial effects. Objective To examine if oral adjunctive therapy with 5,000IU vitD3 or 2x500 mg PBA PBA+vitD3 standard chemotherapy would lead enhanced recovery in sputum smear-positive pulmonary TB patients....

10.1371/journal.pone.0138340 article EN cc-by PLoS ONE 2015-09-22

Background. Streptococcus pneumoniae forms part of the normal nasopharyngeal flora but can also cause a broad spectrum inflammatory diseases. Vitamin D has potent effects on human immunity, including induction antimicrobial peptides and suppression T-cell proliferation, its ability to modulate immune response pneumococci is unknown. Methods. Monocyte-derived dendritic cells (DCs) were stimulated with pneumococcal peptidoglycan (PGN) in presence or absence vitamin D. Expression maturation...

10.1093/infdis/jit355 article EN The Journal of Infectious Diseases 2013-08-06

Abstract Background A 2017 meta-analysis of data from 25 randomised controlled trials vitamin D supplementation for the prevention acute respiratory infections revealed a protective effect intervention. Since then, 20 new RCTs have been completed. Methods Systematic review and (RCTs) ARI using random effects model. Pre-specified sub-group analyses were done to determine whether on risk varied according baseline 25-hydroxyvitamin (25[OH]D) concentration or dosing regimen. We searched MEDLINE,...

10.1101/2020.07.14.20152728 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-07-17

Many immunocompromised patients mount suboptimal humoral immunity after SARS-CoV-2 mRNA vaccination. Here, we assessed the single-cell profile of SARS-CoV-2-specific T cells post-mRNA vaccination in healthy individuals and with various forms immunodeficiencies. Impaired vaccine-induced cell-mediated was observed many patients, particularly solid-organ transplant chronic lymphocytic leukemia patients. Notably, an inherited lack mature B cells, i.e., X-linked agammaglobulinemia (XLA) displayed...

10.1016/j.immuni.2022.07.005 article EN cc-by Immunity 2022-07-19

Mpox represents a persistent health concern with varying disease severity. Reinfections mpox virus (MPXV) are rare, possibly indicating effective memory responses to MPXV or related poxviruses, notably vaccinia (VACV) from smallpox vaccination. We assessed cross-reactive and virus-specific CD4

10.1016/j.chom.2023.04.015 article EN cc-by Cell Host & Microbe 2023-04-25

Although evidence has shown that vitamin D (VD) influences gut homeostasis, limited knowledge is available how VD regulates intestinal immunity against bacterial infection. In the present study, cyp2r1 mutant zebrafish, lacking capacity to metabolize VD, and zebrafish fed a diet devoid of were utilized as VD-deficient animal models. Our results confirmed expression antimicrobial peptides (AMPs) IL-22 was restrained susceptibility infection increased in zebrafish. Furthermore, induced AMP...

10.1080/19490976.2023.2187575 article EN cc-by Gut Microbes 2023-03-06
Coming Soon ...